(Q42628264)

4 November 2017

title

Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni (English)

1 reference

4 November 2017

0 references

1 reference

1 reference

1

G Ritter

1 reference

4 November 2017

7

L J Old

1 reference

4 November 2017

S R Fortunato

2

1 reference

4 November 2017

L Cohen

3

1 reference

4 November 2017

Y Noguchi

4

1 reference

4 November 2017

E M Bernard

5

1 reference

4 November 2017

E Stockert

6

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

International Journal of Cancer

4 November 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 November 2017

volume

66

1 reference

4 November 2017

issue

2

1 reference

4 November 2017

page(s)

184-190

1 reference

Electrophoretic separation of lipopolysaccharide monomers differing in polysaccharide length

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

T cell independent antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Serological analysis of cell surface antigens of malignant human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Specificity and structure of murine monoclonal antibodies against GM1 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

The chemical structure of bacterial endotoxin in relation to bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Immunogenicity of melanoma-associated gangliosides in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819960410%2966%3A2%3C184%3A%3AAID-IJC8%3E3.0.CO%3B2-Z

10.1002/(SICI)1097-0215(19960410)66:2<184::AID-IJC8>3.0.CO;2-Z

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference